Downregulation of UBA1 expression in myelodysplastic neoplasm-Reference-Cited by-同舟云学术

Downregulation of UBA1 expression in myelodysplastic neoplasm

Published:2024-08-23 Issue: Volume: Page:
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Wei Yue^ORCID,Zheng Hong,Li Ziyi,Lockyer Pamela Pennington,Darbaniyan Faezeh,Kanagal-Shamanna Rashmi^ORCID,Yang Hui,Hammond Danielle^ORCID,Garcia-Manero Guillermo^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41375-024-02364-x.pdf

Reference15 articles.

1. Beck DB, Grayson PC, Kastner DL. Mutant UBA1 and Severe Adult-Onset Autoinflammatory Disease. Reply. N Engl J Med. 2021;384:2164–5.

2. Zhao LP, Schell B, Sebert M, Kim R, Lemaire P, Boy M, et al. Prevalence of UBA1 mutations in MDS/CMML patients with systemic inflammatory and auto-immune disease. Leukemia. 2021;35:2731–3.

3. Ferrada MA, Savic S, Cardona DO, Collins JC, Alessi H, Gutierrez-Rodrigues F, et al. Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis. Blood. 2022;140:1496–506.

4. Wei Y, Zheng H, Bao N, Kanagal-Shamanna R, Class C, Yang H, et al. KDM6B Overexpression and TET2 Deficiency Cooperatively Drive Development of Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia-like Phenotype in Mice. Blood. 2019;134:562.

5. Goto Y, Kimura H. Inactive X chromosome-specific histone H3 modifications and CpG hypomethylation flank a chromatin boundary between an X-inactivated and an escape gene. Nucleic Acids Res. 2009;37:7416–28.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SF3B1-mutant mis-splicing ofUBA1confers a targetable therapeutic vulnerability through UBA1 inhibition;2024-08-28